GW Pharmaceuticals PLC (NASDAQ:GWPH)

145.46
Delayed Data
As of Aug 23
 -1.89 / -1.28%
Today’s Change
90.14
Today|||52-Week Range
196.00
+49.36%
Year-to-Date

Today’s Trading

Previous close147.35
Today’s open145.57
Day’s range144.97 - 149.18
Volume296,375
Average volume (3 months)414,402
Market cap$4.8B
Data as of 4:00pm ET, 08/23/2019

Growth & Valuation

Earnings growth (last year)-45.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+42.59%
Revenue growth (last year)+48.41%
P/E ratioNM
Price/Sales178.39
Price/Book6.79

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp-1.80-1.94%
ALLKAllakos Inc-0.95-1.09%
ACADACADIA Pharmaceutica...-1.16-3.97%
HZNPHorizon Therapeutics...-0.49-1.77%
Data as of 4:00pm ET, 08/23/2019

Financials

Next reporting dateNovember 6, 2019
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$15.5M
Annual profit (last year)-$272.7M
Net profit margin-1,760.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts